MARY BAKER: Open Payments
NPI 1659336972 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,167 in 117 payments from 26 companies in 2025. Trend: 2023 $1,927 · 2024 $2,568 · 2025 $2,167
Food & beverage: $2,167
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 22 | $400 |
| Janssen Biotech, Inc. | 12 | $208 |
| AstraZeneca Pharmaceuticals LP | 11 | $199 |
| E.R. Squibb & Sons, L.L.C. | 11 | $178 |
| Novartis Pharmaceuticals Corporation | 11 | $144 |
| Merck Sharp & Dohme LLC | 8 | $139 |
| Alkermes, Inc. | 1 | $114 |
| Eisai Inc. | 6 | $102 |
| Caris MPI, Inc. | 4 | $89 |
| Agios Pharmaceuticals, Inc. | 4 | $71 |
Products named: Enhertu, OPDIVO, KEYTRUDA, LYNPARZA, VIVITROL, Vanflyta, Lenvima, TALVEY.
Industry payments across NJ — which companies pay providers there.
